Abstract
The present report describes the first recognized case of cytomegalovirus (CMV) colitis following azacitidine therapy. A 66-year-old woman with myelodysplastic syndrome developed CMV colitis, which responded to treatment with ganciclovir. Currently, patients receiving azacitidine do not undergo CMV testing, or receive prophylaxis or CMV-free blood products; however, this policy needs to be revised. ©2011 Pulsus Group Inc. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Khan, R., Rudkin, P., Grewal, K., Leonard, J., Hamodat, M., Hutchinson, J., & Daley, P. (2011). Cytomegalovirus colitis following azacitidine therapy. Canadian Journal of Infectious Diseases and Medical Microbiology, 22(3). https://doi.org/10.1155/2011/616725
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
